Laurion Capital Management LP Cure Vac N.V. Transaction History

Laurion Capital Management LP

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 13, 2021	SELL	$56.91 - $127.53 $227,640 - $510,120	-4,000 Closed	0 $0
Q4 2020 Feb 12, 2021	SELL	$46.76 - $136.27 $1.06 Million - $3.09 Million	-22,700 Reduced 85.02%	4,000 $324,000
Q3 2020 Nov 13, 2020	BUY	$43.8 - $77.2 $1.17 Million - $2.06 Million	26,700 New	26,700 $1.24 Million

12.2M

164K

117K

Ticker CVAC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 187,467,008
Market Cap $699M
Description
CureVac N.V., a clinical-stage biopharmaceutical company, focuses on developing various transformative medicines based on messenger ribonucleic acid (mRNA). It is developing prophylactic vaccines, such as mRNA-based vaccine candidates CV2CoV, which is in Phase 1 clinical trial against SARS-CoV-2; CV7202, a prophylactic mRNA-based vaccine, which ...

Get notified when there are updates to the investment portfolio of Laurion Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Laurion Capital Management LP with notifications on news.